American Association of Endocrine Surgeon| Volume 146, ISSUE 6, P1014-1020, December 2009

Effectiveness of “office”-based, ultrasound-guided differential jugular venous sampling (DJVS) of parathormone in patients with primary hyperparathyroidism


      Pre-operative localization is the first step for focused parathyroidectomy. Surgeon-performed ultrasonography (SUS) is used often as a single method of localization; however, when equivocal, sestamibi (MIBI) scan is still indicated. Intra-operative differential jugular venous sampling (DJVS) is positive in 71–80% of patients. The purpose of this study is to evaluate the effectiveness of office based DJVS as the next method for localization when SUS is equivocal.


      Twenty-one patients with an equivocal SUS underwent office-based, SUS-guided DJVS. The samples were collected from the most inferior portion of each internal jugular vein and sent for standard parathormone (PTH) measurement. The side of the neck with the highest value of serum PTH was the initial side of exploration. DJVS lateralization was correlated retrospectively with operative findings.


      In 17 of 21 (81%) patients, DJVS was correct in indicating the side of the abnormal gland. DJVS was incorrect in 2 and negative in 2 other patients. Bilateral neck explorations were performed in only 6 of 21 patients because of either multiglandular disease (3 patients), concomitant thyroidectomy (2 patients), or surgeon's judgment (1 patient). There were no complications from DJVS, and all patients became eucalcemic.


      Office based DJVS is accurate and may eliminate the need for MIBI in patients with equivocal SUS. This simple technique can shorten the pre-operative evaluation of sporadic primary hyperparathyroidism.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Solorzano C.C.
        • Carneiro-Pla D.M.
        • Irvin III, G.L.
        Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism.
        J Am Coll Surg. 2006; 202: 18-24
        • Carneiro-Pla D.M.
        • Solorzano C.C.
        • Irvin III, G.L.
        Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring.
        J Am Coll Surg. 2006; 202: 715-722
        • Parikshak M.
        • Castillo E.D.
        • Conrad M.F.
        • Talpos G.B.
        Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism.
        Am Surg. 2003; 69: 393-399
        • Ito F.
        • Sippel R.
        • Lederman J.
        • Chen H.
        The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing.
        Ann Surg. 2007; 245: 959-963
        • Lal A.
        • Chen H.
        The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?.
        Ann Surg Oncol. 2007; 14: 2363-2366
        • Carneiro D.M.
        • Solorzano C.C.
        • Nader M.C.
        • Ramirez M.
        • Irvin III, G.L.
        Comparison of intraoperative PTH assay (QPTH) criteria in guiding parathyroidectomy: which one is the most accurate?.
        Surgery. 2003; 134: 973-979
        • Irvin G.L.
        • Carneiro D.M.
        Rapid parathyroid hormone assay guided exploration.
        Operative Tech Gen Surg. 1999; 1: 18-25
        • Carneiro-Pla D.M.
        • Solorzano C.C.
        • Lew J.I.
        • Irvin 3rd, G.L.
        Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy.
        Surgery. 2008; 144: 989-993
        • Siperstein A.
        • Berber E.
        • Barbosa G.F.
        • Tsinberg M.
        • Greene A.B.
        • Mitchell J.
        • et al.
        Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases.
        Ann Surg. 2008; 248: 420-428
        • Chen H.
        • Mack E.
        • Starling J.R.
        A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy. Which is most reliable?.
        World J Surg. 2004; 28: 1132-1138
        • Friedman K.
        • Somervell H.
        • Patel P.
        • Melton G.B.
        • Garrett-Mayer E.
        • Dackiw A.P.
        Effect of calcium channel blockers on the sensitivity of preoperative 99m Tc-MIBI SPECT for hyperparathyroidism.
        Surgery. 2004; 136: 1199-1204
        • Melton G.
        • Somervell H.
        • Friedman K.
        • Zeiger M.A.
        • Cahid Civelek A.
        Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together.
        Nucl Med Commun. 2005; 26: 633-638
        • Rodgers S.E.
        • Hunter G.J.
        • Hamberg L.M.
        • Schellingerhout D.
        • Doherty D.B.
        • Ayers G.D.
        • et al.
        Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography.
        Surgery. 2006; 140: 932-941
        • Irvin G.L.
        • Carneiro D.M.
        Intraoperative parathyroid hormone assay as a surgical adjunct in patients with sporadic primary hyperarathyroidism.
        in: Clark O. Duh Q.Y. Textbook of endocrine surgery. 2nd edition. Springer, New York2005